NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Pivotal bioVenture Partners

Pivotal bioVenture Partners

San Francisco, Californiapivotallifesciences.com

Overview

Pivotal bioVenture Partners is a venture capital firm and the venture arm of Pivotal Life Sciences that invests in North American and European companies focused on innovative therapeutic products and platforms.

Year Founded

2017

Portfolio Companies

34

Investments

Pivotal bioVenture Partners investments
CompanyDateStageLead
ImmuneBiotechMay 2026Growth EquityCo-investor
Windward BioMay 2026VC RoundCo-investor
Obsidian TherapeuticsApr 2026Private EquityCo-investor
NeuShen TherapeuticsJan 2026Series A ExtensionCo-investor
Addition TherapeuticsDec 2025Series A ExtensionLead

Key People

Shiva Amiri

Partner, Chief Data Science Officer

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersSan Francisco, California
Year Founded2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.